4
Changes in Ownership
Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-21-031376
EVP and Chief Medical Officer sold 364 shares at $113.67 ($41,376)
From the SEC's structured data for this filing
Trades in this filing
Bedrosian Camille L · EVP and Chief Medical Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-05-06 | Sale : show line 1 in the form | −364 | $113.67 | $41,376 | 38,775 | D |
| Open-market sales · 364 sh · avg $113.67 · $41,376 | ||||||
Loading xslF345X03/doc4.xml…